Depigmentation therapy in vitiligo universalis with cryotherapy and 4-hydroxyanisole

Clinical and Experimental Dermatology

Volumn 35, Issue 2, 2010, Pages 215-216

  Nuzzo, S Di ^a   Masotti, A ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MEQUINOL; ANISOLE DERIVATIVE; ANTIOXIDANT;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; CASE REPORT; CHEEK; CORTICOSTEROID THERAPY; CRYOTHERAPY; DEPIGMENTATION; EAR; ERYTHEMA; EYELID; HUMAN; MALE; PHOTOTHERAPY; PRIORITY JOURNAL; SKIN EDEMA; SKIN PIGMENTATION; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT FAILURE; VITILIGO; VITILIGO UNIVERSALIS; MELANOCYTE; PROCEDURES; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AGED; ANISOLES; ANTIOXIDANTS; CRYOTHERAPY; HUMANS; MALE; MELANOCYTES; SKIN PIGMENTATION; TREATMENT OUTCOME; VITILIGO;

EID: 75849156114     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03412.x     Document Type: Article

References (5)

1. Njoo MD, Vodegel RM, Westerhof W. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser. J Am Acad Dermatol 2000 42: 760 769.
2. Rao J, Fitzpatrick RE. Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo. Dermatol Surg 2004 30: 1043 1045.
3. Radmanesh M. Depigmentation of the normally pigmented patches in universal vitiligo patients by cryotherapy. J Eur Acad Dermatol Venereol 2000 14: 149 152.
4. Hedges TR III., Kenyon KR, Hanninen LA, Mosher DB. Corneal and conjunctival effects of monobenzone in patients with vitiligo. Arch Ophthalmol 1983 101: 64 8.
5. Riley PA. Hydroxyanisole depigmentation: in-vivo studies. J Pathol 1969 97: 185 191.